ITEM 7.01 REGULATION FD DISCLOSURE.
On July 2, 2014, China Biologic Products, Inc. (the "Company") completed an
offering (the "Offering") of 1,782,500 shares of its common stock at a price of
$38.00 per share, less the underwriting discounts. In the Offering, the Company
sold 920,000 shares (including 120,000 shares sold pursuant to the exercise by
the underwriters of their option to purchase additional shares from the Company)
and a selling stockholder sold 862,500 shares (including 112,500 shares sold
pursuant to the exercise by the underwriters of their option to purchase
additional shares from such selling stockholder).
The Offering was made pursuant to three shelf registration statements that are
already effective with the Securities and Exchange Commission.
The information contained in this report shall not be deemed to be "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended
("Exchange Act"), or otherwise subject to the liabilities of that section, nor
shall such information be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.